Cargando…
Current use of statins reduces risk of HIV rebound on suppressive HAART
BACKGROUND: Despite compelling evidence for activity against HIV-1 in vitro, a virologic effect of statins has not been shown in clinical studies. Given their short plasma half-lives, such an effect may be transient and only apparent during ongoing exposure. METHODS: We studied all HIV infected US-V...
Autores principales: | Drechsler, Henning, Ayers, Colby, Cutrell, James, Maalouf, Naim, Tebas, Pablo, Bedimo, Roger |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5331966/ https://www.ncbi.nlm.nih.gov/pubmed/28249009 http://dx.doi.org/10.1371/journal.pone.0172175 |
Ejemplares similares
-
Consistent use of lipid lowering therapy in HIV infection is associated with low mortality
por: Drechsler, Henning, et al.
Publicado: (2021) -
The RADAR Study: Week 48 Safety and Efficacy of RAltegravir Combined with Boosted DARunavir Compared to Tenofovir/Emtricitabine Combined with Boosted Darunavir in Antiretroviral-Naive Patients. Impact on Bone Health
por: Bedimo, Roger J., et al.
Publicado: (2014) -
The management of treatment-experienced HIV patients (including
virologic failure and switches)
por: Cutrell, James, et al.
Publicado: (2020) -
538. Integrase Inhibitor-Based HAART Is Associated with Greater BMI Gains in Blacks, Hispanics, and Women
por: Bedimo, Roger, et al.
Publicado: (2018) -
Deep Molecular Characterization of HIV-1 Dynamics under Suppressive HAART
por: Buzón, Maria J., et al.
Publicado: (2011)